SOUTH SAN FRANCISCO, Calif., July 14, 2020 /PRNewswire/ — IDEAYA Biosciences, Inc. (Nasdaq: IDYA), an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics, announced the Company will parti… […]
– Strong anti-VEGF safety, efficacy and durability continue to be observed across all three of the major retinal vascular diseases, with most patients achieving treatment-free intervals of 6-months in wet AMD, 6-months or longer in DME, and 4-months o… […]
TAVLESSE initial launch in Germany and the U.K. by Grifols S.A.
SOUTH SAN FRANCISCO, Calif., July 9, 2020 /PRNewswire/ — Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today announced that Grifols S.A., its collaborative partner in Europe, has launched … […]
SOUTH SAN FRANCISCO, Calif., July 9, 2020 /PRNewswire/ — IDEAYA Biosciences, Inc. (NASDAQ:IDYA), an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics, announced First-Patient-In (FPI) in… […]
SAN FRANCISCO, July 8, 2020 /PRNewswire/ — ValGenesis, Inc., a market leader in Enterprise Validation Lifecycle Management solutions, today announced that a fast growing research based biopharmaceutical company has chosen the ValGenesis Validation … […]
HAYWARD, Calif., July 8, 2020 /PRNewswire/ — Benitec Biopharma, Inc. (NASDAQ: BNTC), a development-stage, gene therapy-focused, biotechnology company developing novel genetic medicines based on the proprietary DNA-directed RNA interference (“ddRNAi… […]
PALO ALTO, Calif., July 7, 2020 /PRNewswire/ — Kodiak Sciences Inc. (Nasdaq: KOD), a clinical stage biopharmaceutical company specializing in novel therapeutics to treat chronic, high-prevalence retinal diseases, today announced that new data from … […]
– Dr. Garret Hampton serves as President, Clinical Sequencing and Oncology at Thermo Fisher Scientific, and held leadership roles at Illumina and Genentech
SOUTH SAN FRANCISCO, Calif., June 30, 2020 /PRNewswire/ — IDEAYA Biosciences, Inc. (NASDAQ:… […]
SOUTH SAN FRANCISCO, Calif., June 29, 2020 /PRNewswire/ — Akero Therapeutics, Inc. (Nasdaq: AKRO) today announced that the company plans to discuss new efficacy and safety data, including biopsy results, from its Phase 2a BALANCED study of AKR-001 … […]
Eurofins DiscoverX announces Catalent Biologics as a North American Certified Biologics Analytical Laboratory
FREMONT, Calif., June 29, 2020 /PRNewswire/ — Eurofins DiscoverX, the products company of Eurofins Discovery, today announced the expansio… […]
Copyright © 2020 | MH Magazine WordPress Theme by MH Themes
